A U.S. Senate bill meant to provide more insurance options for individuals living in markets with no HealthCare.gov plans could exacerbate the problem by taking away both participation incentives and money from insurers.
Senate Republicans on Thursday needed Vice President Mike Pence to break a tie on legislation to reverse an Obama administration rule protecting funds for Planned Parenthood and other family planning providers.
Enrollment on the Affordable Care Act's federal marketplaces dropped almost everywhere this year, amid the Republican push for the healthcare law's repeal and the widespread sentiment that the insurance exchanges were going under. But Utah was a spot of hope for Obamacare supporters.
Summa Health's emergency medicine residency program will lose its accreditation after the system's appeal was denied, according to a March 29 staff memo.
Kansas lawmakers are considering whether to override Gov. Sam Brownback's veto of their Medicaid expansion bill. Patients and providers say lots of uninsured working people would benefit by gaining better access to preventive care.
Iowa's controversial move to privatize its Medicaid program has cost participating insurers an estimated $450 million in losses.
The CMS is delaying a rule that would result in clinical labs losing $3.93 billion in Medicare payments over 10 years.
Higi, a healthcare company launched by now-Tronc Chairman Michael Ferro, has received an undisclosed investment from Blue Cross and Blue Shield's venture fund, according to a statement on the company's website.
The makers of three popular health-related mobile apps have reached settlements with the New York attorney general's office over allegations that they could have harmed consumers by giving them wrong or misleading results.
Dialysis providers claim a proposed California law that would mandate staffing ratios and yearly inspections at dialysis clinics is too restrictive and won't improve patient care.
The head of Laboratory Corporation of America Holdings' hospitals and health systems group will now lead the company's entire diagnostics segment.
Share your opinion in the latest edition of our bi-weekly reader poll. Is your healthcare organization making changes in response to the nation's opioid epidemic?